ibhena yephepha

Coenzyme Q10 10% |303-98-0

Coenzyme Q10 10% |303-98-0


  • Igama Eliqhelekileyo:Coenzyme Q10 10%
  • Inombolo yeCAS:303-98-0
  • Inombolo ye-EINECS:206-147-9
  • Imbonakalo:Umgubo oMthubi ukuya kweOrenji
  • Ifomula yemolekyuli:C59H90O4
  • Ubuninzi kwi-20' FCL:20MT
  • Min.Iodolo:25KG
  • Igama lebrand:Colorcom
  • Beka ubomi kwishelufa:iminyaka eyi-2
  • Indawo yemvelaphi:eTshayina
  • Umqulu:25 kgs/ibhegi okanye njengoko ucela
  • Ugcino:Gcina kwindawo engenamoya, kwindawo eyomileyo
  • Imigangatho eyenziweyo:Umgangatho wamazwe ngamazwe
  • Inkcazo yeMveliso:Q10 10%
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Ingcaciso yeMveliso:

    I-Coenzymes yiklasi yeemolekyuli ezincinci zezinto eziphilayo ezinokudlulisa amaqela ekhemikhali ukusuka kwi-enzyme enye ukuya kwenye.Zibotshelelwe ngokukhululekileyo kwi-enzyme kwaye ziyimfuneko kumsebenzi we-enzyme ethile.

    1. Umsebenzi wokukhuthaza i-phosphorylation ye-oxidative kunye nokukhusela ukunyaniseka kwesakhiwo se-biofilms.Yikhompawundi yequinone enyibilikayo ngamafutha ekhoyo ngokubanzi kwizinto eziphilayo.Yinto esebenzayo yokuphefumla kweselula kunye nemetabolism yeselula, kwaye ikwayinto ebalulekileyo yokulwa ne-antioxidant kunye neyongezelelekileyo yokuzikhusela komzimba.iarhente.
    2. Inokunciphisa ubuthathaka be-contractility ye-myocardial kunye nomxholo we-creatine phosphate kunye ne-adenosine triphosphate ngexesha le-ischemia enzima, igcine i-morphological structure ye-ischemic myocardial cell mitochondria, kwaye ibe nefuthe elithile lokukhusela kwi-ischemic myocardium.
    3. Ukwandisa imveliso yenhliziyo, ukunciphisa ukunyanzeliswa kwe-peripheral, ukuncedisa unyango lwe-anti-heart failure, kunokuthintela ukudibanisa kunye nokukhupha i-aldosterone kunye nokuthintela umphumo wayo kwii-tubules ze-renal.
    4. Ngaphantsi kwe-hypoxia, ixesha lesenzo se-myocardial sinokufinyezwa, umda we-ventricular arrhythmia uphezulu kunezilwanyana zokulawula, ukuchasana kwe-vascular peripheral kungancipha, kwaye kune-anti-aldosterone effect.


  • Ngaphambili:
  • Okulandelayo: